In this U01 grant we propose a 5 year engineering development effort to advance Magnetic Particle Imaging (MPI) to replace MRI as the next-generation functional brain imaging tool for human neuroscience. MPI is a young but extremely promising technology that uses the non-linear magnetic response of ironoxide nanoparticles to localize their presence in the body. MPI directly detects the nanoparticle's magnetization rather than using secondary effects on the Magnetic Resonance relaxation times. Thus, while MPI and MRI share many technologies, the MPI method does not use the MR phenomena in any way. Our plan is to detect the activation-induced and resting-state changes in the iron-oxide concentration in the cerebral capillary network by monitoring the local iron oxide concentration (and thus local Cerebral Blood Volume, CBV). This CBV-contrast source is well- proven in animal and human fMRI studies which detect CBV changes by MRI using the same iron- oxide agents, but indirectly. But, by developing MPI as the detection modality, we show that there is a potential 10-fold increase in the contrast-to-noise ratio (CNR) of human neuronal activation. In the planning grant stage, we analyzed multiple potential MPI scanner designs for humans and settled on a Field-Free-Line geometry. We developed the simulation tools to model the performance of a human sized instrument. Additionally, we validated our modeling by building and testing a small, rodent-scale MPI detector in our lab at MGH. Using this device, we showed the first ever demonstration of functional imaging with MPI using a rodent hypercapnia model. In this U01 phase we seek the resources to construct and validate the human scale, rotating FFL-style MPI device analyzed in the planning grant. After construction, we will validate its performance in phantom studies, and also in an awake-behaving macaque model that we have previously used for fMRI studies. Finally, we will validate the performance of the device in limited human fMPI studies. By developing a new and more sensitive detection methodology for functional human imaging, we hope to add a powerful new non-invasive methods to the tools available to neuroscientists studying the human brain in health and disease.

Public Health Relevance

In this grant we propose a 5 year engineering development effort to develop Magnetic Particle Imaging (MPI) as a method for imaging the function of the human brain in health and disease. By producing a method that allows us to ?see? the brain in operation with a clarity of up to 10-fold higher than existing MRI based methods, we hope to significantly impact our understanding of disease mechanisms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01EB025121-01
Application #
9418281
Study Section
Special Emphasis Panel (ZEB1)
Program Officer
Wang, Shumin
Project Start
2017-09-26
Project End
2022-08-31
Budget Start
2017-09-26
Budget End
2018-08-31
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114